drugset / Trial / NCT01425788
Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense
Phase 2
Completed
236 enrolled
ALK-Abelló A/S
ACM Pivotal Global Central Laboratory · collabBrecon Pharmaceuticals Ltd · collabErgomed GmbH · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this trial is to investigate the tolerability of Osiris Phleum pratense used with 2 simplified up-dosing schedules compared to the up-dosing schedule used in current practice.
Timeline
- Start
- 2011-08
- Primary completion
- 2011-11
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Osiris Phleum pratense | Unknown | 300 unknown | — |